Tianda Pharmaceuticals Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tianda Pharmaceuticals Ltd with three other
pharmaceutical manufacturers in Asia:
WooGene B&G CO., LTD
of South Korea
sales of 27.82 billion Korean Won [US$24.73 million]
Twi Pharmaceuticals Inc
(743.78 million Taiwanese Dollars [US$24.67 million]
of which 100%
was Generic Drug), and
Pharmicell Company Limited
based in South Korea
(27.84 billion Korean Won [US$24.75 million]
of which 83%
During the year ended March of 2016, sales at
Tianda Pharmaceuticals Ltd were HK$192.78 million (US$24.75 million).
increase of 38.3%
versus 2015, when the company's sales were HK$139.37 million.
Despite this increase, sales are still
below the level achieved in 2014, when Tianda Pharmaceuticals Ltd
reported sales of HK$247.17 million.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Tianda Pharmaceuticals Ltd had sales
of HK$206.35 million.